{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:51:07Z","timestamp":1762145467429},"reference-count":46,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,9,27]]},"DOI":"10.1536\/ihj.19-065","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:08:28Z","timestamp":1567534108000},"page":"1168-1175","source":"Crossref","is-referenced-by-count":9,"title":["Effects of Angiotensin Receptor Neprilysin Inhibitors on Inducibility of Ventricular Arrhythmias in Rats with Ischemic Cardiomyopathy"],"prefix":"10.1536","volume":"60","author":[{"given":"Jun-Yu","family":"Huo","sequence":"first","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Tian","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Jun","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Thom T, Haase N, Rosamond W, <i>et al<\/i>. Heart disease and stroke statistics--2006 update: A report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2006; 113: e85-e151.","DOI":"10.1161\/CIRCULATIONAHA.105.171600"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bunch TJ, Hohnloser SH, Gersh BJ. Mechanisms of sudden cardiac death in myocardial infarction survivors: Insights from the randomized trials of implantable cardioverter-defibrillators. Circulation 2007; 115: 2451-7.","DOI":"10.1161\/CIRCULATIONAHA.106.683235"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ajijola OA, Yagishita D, Patel KJ, <i>et al<\/i>. Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: Neural remodeling in a spatial context. Am J Physiol Heart Circ Physiol 2013; 305: H1031-40.","DOI":"10.1152\/ajpheart.00434.2013"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989; 69: 1049-169.","DOI":"10.1152\/physrev.1989.69.4.1049"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Xu B, Xu H, Cao H, <i>et al<\/i>. Intermedin improves cardiac function and sympathetic neural remodeling in a rat model of post myocardial infarction heart failure. Mol Med Rep 2017; 16: 1723-30.","DOI":"10.3892\/mmr.2017.6776"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yang N, Cheng W, Hu H, <i>et al<\/i>. Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of m2 macrophages in rats postmyocardial infarction. Cardiovasc Ther 2016; 34: 234-44.","DOI":"10.1111\/1755-5922.12193"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vasquez C, Benamer N, Morley GE. The cardiac fibroblast: Functional and electrophysiological considerations in healthy and diseased hearts. J Cardiovasc Pharmacol 2011; 57: 380-8.","DOI":"10.1097\/FJC.0b013e31820cda19"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Volpe M, Tocci G, Battistoni A, Rubattu S. Angiotensin ii receptor blocker neprilysin inhibitor (arni): New avenues in cardiovascular therapy. High Blood Press Cardiovasc Prev 2015; 22: 241-6.","DOI":"10.1007\/s40292-015-0112-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ruilope LM, Dukat A, Bohm M, Lacourciere Y, Gong J, Lefkowitz MP. Blood-pressure reduction with lcz696, a novel dual-acting inhibitor of the angiotensin ii receptor and neprilysin: A randomised, double-blind, placebo-controlled, active comparator study. Lancet 2010; 375: 1255-66.","DOI":"10.1016\/S0140-6736(09)61966-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. von Lueder TG, Wang BH, Kompa AR, <i>et al<\/i>. Angiotensin receptor neprilysin inhibitor lcz696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ Heart Fail 2015; 8: 71-8.","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. McMurray JJ, Packer M, Desai AS, <i>et al<\/i>. Baseline characteristics and treatment of patients in prospective comparison of arni with acei to determine impact on global mortality and morbidity in heart failure trial (paradigm-hf). Eur J Heart Fail 2014; 16: 817-25.","DOI":"10.1002\/ejhf.115"},{"key":"12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","volume":"15","year":"2018","unstructured":"12. de Diego C, Gonzalez-Torres L, Nunez JM, <i>et al<\/i>. Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices. Heart Rhythm 2018; 15: 395-402.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gu J, Noe A, Chandra P, <i>et al<\/i>. Pharmacokinetics and pharmacodynamics of lcz696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (arni). J Clin Pharmacol 2010; 50: 401-14.","DOI":"10.1177\/0091270009343932"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Trivedi RK, Polhemus DJ, Li Z, <i>et al<\/i>. Combined angiotensin receptor-neprilysin inhibitors improve cardiac and vascular function via increased no bioavailability in heart failure. J Am Heart Assoc 2018; 7: e008268.","DOI":"10.1161\/JAHA.117.008268"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Cao JM, Fishbein MC, Han JB, <i>et al<\/i>. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000; 101: 1960-9.","DOI":"10.1161\/01.CIR.101.16.1960"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cao JM, Chen LS, KenKnight BH, <i>et al<\/i>. Nerve sprouting and sudden cardiac death. Circ Res 2000; 86: 816-21.","DOI":"10.1161\/01.RES.86.7.816"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Meiri KF, Pfenninger KH, Willard MB. Growth-associated protein, gap-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A 1986; 83: 3537-41.","DOI":"10.1073\/pnas.83.10.3537"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chen PS, Chen LS, Cao JM, Sharifi B, Karagueuzian HS, Fishbein MC. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res 2001; 50: 409-16.","DOI":"10.1016\/S0008-6363(00)00308-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gradin KA, Li JY, Andersson O, Simonsen U. Enhanced neuropeptide y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res 2003; 40: 252-65.","DOI":"10.1159\/000071889"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ananda S, Wang Y, Zhu S, <i>et al<\/i>. Role of neuropeptide y and peroxisome proliferator-activated receptor gamma coactivator-1alpha in stress cardiomyopathy. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 823-8.","DOI":"10.1007\/s11596-012-1041-3"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Roell W, Lewalter T, Sasse P, <i>et al<\/i>. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007; 450: 819-24.","DOI":"10.1038\/nature06321"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Docherty KF, McMurray JJV. Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction. Int J Cardiol 2019; 281: 179-85.","DOI":"10.1016\/j.ijcard.2018.05.124"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kompa AR, Lu J, Weller TJ, <i>et al<\/i>. Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction. Int J Cardiol 2018; 258: 192-8.","DOI":"10.1016\/j.ijcard.2018.01.077"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Solomon SD, Claggett B, Desai AS, <i>et al<\/i>. Influence of ejection fraction on outcomes and efficacy of sacubitril\/valsartan (lcz696) in heart failure with reduced ejection fraction: The prospective comparison of arni with acei to determine impact on global mortality and morbidity in heart failure (paradigm-hf) trial. Circ Heart Fail 2016; 9: e002744.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002744"},{"key":"25","unstructured":"25. Li CY, Li YG. Cardiac sympathetic nerve sprouting and susceptibility to ventricular arrhythmias after myocardial infarction. Cardiol Res Pract 2015; 2015: 698368."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hu J, Wang X, Tang YH, <i>et al<\/i>. Activin a inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats. Mol Med Rep 2018; 17: 5074-80.","DOI":"10.3892\/mmr.2018.8496"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kalla M, Herring N, Paterson DJ. Cardiac sympatho-vagal balance and ventricular arrhythmia. Auton Neurosci 2016; 199: 29-37.","DOI":"10.1016\/j.autneu.2016.08.016"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Schwartz PJ, Priori SG, Cerrone M, <i>et al<\/i>. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-qt syndrome. Circulation 2004; 109: 1826-33.","DOI":"10.1161\/01.CIR.0000125523.14403.1E"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Jackson N, Gizurarson S, Azam MA, <i>et al<\/i>. Effects of renal artery denervation on ventricular arrhythmias in a postinfarct model. Circ Cardiovasc Interv 2017; 10: e004172.","DOI":"10.1161\/CIRCINTERVENTIONS.116.004172"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Jiang Z, Zhou X, Chen C, <i>et al<\/i>. Renal denervation for ventricular arrhythmia in patients with implantable cardioverter defibrillators. Int Herat J 2018; 59: 328-32.","DOI":"10.1536\/ihj.17-129"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Polhemus DJ, Trivedi RK, Gao J, <i>et al<\/i>. Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney. J Am Coll Cardiol 2017; 70: 2139-53.","DOI":"10.1016\/j.jacc.2017.08.056"},{"key":"32","unstructured":"32. Pascual-Figal DA. Neprilysin and heart failure: A &quot;sympathetic&quot; relationship? J Am Coll Cardiol 2017; 70: 2154-6."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Zhang P, Shao L, Ma J. Toll-like receptors 2 and 4 predict new-onset atrial fibrillation in acute myocardial infarction patients. Int Heart J 2018; 59: 64-70.","DOI":"10.1536\/ihj.17-084"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Rockey DC, Bell PD, Hill JA. Fibrosis--a common pathway to organ injury and failure. N Engl J Med 2015; 372: 1138-49.","DOI":"10.1056\/NEJMra1300575"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358: 1370-80.","DOI":"10.1056\/NEJMra072139"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev 2007; 87: 1285-342.","DOI":"10.1152\/physrev.00012.2007"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Weber KT. Cardiac interstitium in health and disease: The fibrillar collagen network. J Am Coll Cardiol 1989; 13: 1637-52.","DOI":"10.1016\/0735-1097(89)90360-4"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Iles L, Pfluger H, Lefkovits L, <i>et al<\/i>. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011; 57: 821-8.","DOI":"10.1016\/j.jacc.2010.06.062"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res 2004; 61: 386-401.","DOI":"10.1016\/j.cardiores.2003.11.039"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Gomes J, Finlay M, Ahmed AK, <i>et al<\/i>. Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-a combined murine and human study. Eur Heart J 2012; 33: 1942-53.","DOI":"10.1093\/eurheartj\/ehr472"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kim E, Fishman GI. Designer gap junctions that prevent cardiac arrhythmias. Trends Cardiovasc Med 2013; 23: 33-8.","DOI":"10.1016\/j.tcm.2012.08.008"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Scott PA, Rosengarten JA, Curzen NP, Morgan JM. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: A meta-analysis. Eur J Heart Fail 2013; 15: 1019-27.","DOI":"10.1093\/eurjhf\/hft053"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Disertori M, Rigoni M, Pace N, <i>et al<\/i>. Myocardial fibrosis assessment by lge is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic lv dysfunction: A meta-analysis. JACC Cardiovascular imaging 2016; 9: 1046-55.","DOI":"10.1016\/j.jcmg.2016.01.033"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Gulati A, Jabbour A, Ismail TF, <i>et al<\/i>. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013; 309: 896-908.","DOI":"10.1001\/jama.2013.1363"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Langenickel TH, Jordaan P, Petruck J, <i>et al<\/i>. Single therapeutic and supratherapeutic doses of sacubitril\/valsartan (lcz696) do not affect cardiac repolarization. Eur J Clin Pharmacol 2016; 72: 917-24.","DOI":"10.1007\/s00228-016-2062-9"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Zile MR, O&apos;Meara E, Claggett B, <i>et al<\/i>. Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with hfref. J Am Coll Cardiol 2019; 73: 795-806.","DOI":"10.1016\/j.jacc.2018.11.042"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/5\/60_19-065\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:03:25Z","timestamp":1569629005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/5\/60_19-065\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-065","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}